Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Applying computational modeling to drug discovery and development.

Neil Kumar1, Bart S Hendriks, Kevin A Janes

  • 1Department of Chemical Engineering, Pfizer Research Technology Center, and Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. nkumar@mit.edu

Drug Discovery Today
|August 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multiplexed, systems-based approach for prediction of antibody neutralization breadth for soluble human receptors.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Breast milk antibody Fc signatures track with HIV transmission during breastfeeding in ART-naïve mothers.

iScience·2026
Same author

A scalable, low-cost, sample hashing workflow for multiomic single-cell analysis using the Seq-Well S<sup>3</sup> platform.

Nature protocols·2026
Same author

Protein networks are influenced by maternal BMI and differentiate preterm birth types.

Communications medicine·2026
Same author

A vascularized liver microphysiological system captures key features of hepatic insulin resistance and monocyte infiltration.

Nature communications·2026
Same author

Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infection.

NPJ vaccines·2026
Same journal

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

Drug discovery today·2026
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
See all related articles

Computational modeling enhances biological understanding and aids drug discovery. These predictive tools help pharmaceutical companies efficiently develop new therapies from molecular targets to organism-level treatments.

Area of Science:

  • Computational biology
  • Systems biology
  • Pharmacology

Background:

  • Biological systems require computational models for deeper comprehension.
  • Modeling is essential for advancing biology from descriptive to predictive science.
  • The pharmaceutical industry increasingly relies on computational approaches for drug development.

Purpose of the Study:

  • To discuss pharmaceutically-relevant computational modeling approaches.
  • To highlight the role of computational biology in the pharmaceutical industry.
  • To demonstrate how computational models improve target-to-therapy efficiency.

Main Methods:

  • Review of current computational modeling techniques in drug discovery.
  • Analysis of pharmaceutically-relevant predictive modeling tools.

Related Experiment Videos

  • Case examples of computational model application in pharmaceutical research.

    • Main Results:

    • Computational models are vital for predicting therapeutic outcomes.
    • These models enhance the efficiency of transforming molecular targets into viable therapies.
    • Pharmaceutical companies can leverage computational approaches for improved drug development pipelines.

    Conclusions:

    • Computational modeling is a cornerstone for predictive biological science.
    • The pharmaceutical industry benefits significantly from integrating computational biology.
    • Optimized use of computational models accelerates the journey from target identification to therapeutic application.